Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery

Genetic Vaccines and Therapy

Volumn 2, Issue , 2004, Pages

  Zhang, Weidong ^a   Singam, Rajeswari ^a   Hellermann, Gary ^a   Kong, Xiaoyuan ^a   San Juan, Homero ^a   Lockey, Richard F ^a   Wu, Shuen Ju ^b   Porter, Kevin ^b   Mohapatra, Shyam S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Adeno associated virus; Dengue virus; Gene expression; siRNA

Indexed keywords

PARVOVIRUS VECTOR; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; GENE CASSETTE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NONHUMAN; SEROTYPE; VERO CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTENUATION; VIRUS REPLICATION;

EID: 13444272367     PISSN: 14790556     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-0556-2-8     Document Type: Article

References (28)

1. Lindenbach B, Rich CM: Flaviviridae:. The Viruses and Their Replication. In: Fields Virology Volume I. 4th edition. Edited by: Knipe DM, Howley PM. Wolters Kluwer Co., Lippincott Williams & Wilkins; 2000:991-1003.
2. Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O: Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002, 21:5864-5874.
3. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ: Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001, 293:1146-1150.
4. Fire A: RNA-triggered gene silencing. Trends Genet 1999, 15:358-363.
5. Blair CD, Adelman ZN, Olson KE: Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes. Clin Microbiol Rev 2000, 13:651-661.
6. Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE: Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 2001, 10:265-273.
7. Caplen NJ, Zheng Z, Falgout B, Morgan RA: Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol Ther 2002, 6: 43-251.
8. Kumar M, Behera AK, Matsuse H, Lockey RF, Mohapatra SS: Intranasal IFN-gamma transfer of prevents respiratory syncytial virus infection in BALB/c mice. Vaccine 1999, 18:558-567.
9. Donnelly JJ, Ulmer JB, Liu MA: DNA vaccines. Dev Biol Stand 1998, 95:43-53.
10. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y: A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002, 99: 515-5520.
11. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH: Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001, 166: 499-1506.
12. Marovich M, Grouard-Vogel G, Louder M, Eller M, Sun W, Wu SJ, Putvatana R, Murphy G, Tassaneetrithep B, Burgess T, Birx D, Hayes C, Schlesinger-Frankel S, Mascola J: Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc 2001, 6:219-224.
13. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS: Human skin Langerhans cells are targets of dengue virus infection. Nature Med 2000, 6:816-820.
14. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
15. Tusch L.T: Expanding small RNA interference. Nat Biotechnol 2002, 20:446-448.
16. Srivastava A: Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors. J Cell Biochem Suppl 2002, 38:39-45.
17. Men R, Bray M, Clark D, Chanock RM, Lai CJ: Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J Virol 1996, 70:3930-3937.
18. Proutski V, Gould EA, Holmes EC: Secondary structure of the 3′ untranslated region of flaviviruses: Similarities and differences. Nucleic Acids Res 1997, 25:1194-1202.
19. Rauscher S, Flamm C, Mandl CW, Heinz FX, Stadler PF: Secondary structure of the 3′-noncoding region of lavivirus genomes: Comparative analysis of base pairing probabilities. RNA 1997, 3:779-791.
20. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA: Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001, 75:3501-3508.
21. Ponnazhagan S, Mahendra G, Curiel DT, Shaw DR: Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy. J Virol 2001, 75:9493-9501.
22. Ilves H, Barske C, Junker U, Bohnlein E, Veres G: Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: A comparative study. Gene 1996, 171: 03-208.
23. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
24. Ludewig B, Oehen S, Barchiesi F, Schwendener RA, Hengartner H, Zinkernagel RM: Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J Immunol 1999, 163:1839-1844.
25. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A: Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 1997, 176:322-330.
26. Bueler H: Adeno-associated viral vectors for gene transfer and gene therapy. Biol Chem 1999, 380:613-622.
27. Kay MA, Glorioso JC, Naldini L: Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nature Med 2001, 7:33-40.
28. Zaiss A, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA: Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002, 76: 580-4590.